UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Silencing effects of mutant RAS signalling on transcriptomes

Advances in biological regulation, 2023-01, Vol.87, p.100936, Article 100936

2023

Volltextzugriff (PDF)

Guidelines for the selection of functional assays to evaluate the hallmarks of cancer

Biochimica et biophysica acta, 2016-12, Vol.1866 (2), p.300-319

2016

Volltextzugriff (PDF)

Ras-mediated deregulation of the circadian clock in cancer

PLoS genetics, 2014-05, Vol.10 (5), p.e1004338

2014

Volltextzugriff (PDF)

Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors

Nature communications, 2017-02, Vol.8 (1), p.14262-14262, Article 14262

2017

Volltextzugriff (PDF)

Editorial: Hallmark of cancer: Evasion of growth suppressors

Frontiers in oncology, 2023-03, Vol.13, p.1170115-1170115

2023

Volltextzugriff (PDF)

Non-Canonical Hedgehog Signaling Is a Positive Regulator of the WNT Pathway and Is Required for the Survival of Colon Cancer Stem Cells

Cell reports (Cambridge), 2017-12, Vol.21 (10), p.2813-2828

2017

Volltextzugriff (PDF)

Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D cultures

PLoS genetics, 2019-03, Vol.15 (3), p.e1008076-e1008076

2019

Volltextzugriff (PDF)

RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data

Breast cancer research and treatment, 2012-04, Vol.132 (3), p.1025-1034

2012

Volltextzugriff (PDF)

Evaluation of JQ1 Combined With Docetaxel for the Treatment of Prostate Cancer Cells in 2D- and 3D-Culture Systems

Frontiers in pharmacology, 2022-02, Vol.13, p.839620-839620

2022

Volltextzugriff (PDF)

Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures

Journal of biomolecular screening, 2016-10, Vol.21 (9), p.931-941

2016

Volltextzugriff (PDF)

Network quantification of EGFR signaling unveils potential for targeted combination therapy

Molecular systems biology, 2013, Vol.9 (1), p.673-n/a

2013

Volltextzugriff (PDF)

A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-NTRK1 gene fusion with durable clinical response to crizotinib: a case report

BMC cancer, 2018-08, Vol.18 (1), p.842-842, Article 842

2018

Volltextzugriff (PDF)

DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer

Nature communications, 2017-01, Vol.8 (1), p.14093-14093, Article 14093

2017

Volltextzugriff (PDF)

The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells

PloS one, 2014-05, Vol.9 (5), p.e92596-e92596

2014

Volltextzugriff (PDF)

HMGA2 gene is a promising target for ovarian cancer silencing therapy

International journal of cancer, 2008-07, Vol.123 (2), p.348-356

2008

Volltextzugriff (PDF)

VIST - a Variant-Information Search Tool for precision oncology

BMC bioinformatics, 2019-08, Vol.20 (1), p.429-429, Article 429

2019

Volltextzugriff (PDF)

IC50: an unsuitable measure for large-sized prostate cancer spheroids in drug sensitivity evaluation

Bosnian journal of basic medical sciences, 2022-07, Vol.22 (4), p.580-592

2022

Volltextzugriff (PDF)

Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells

PLoS genetics, 2010-12, Vol.6 (12), p.e1001231-e1001231

2010

Volltextzugriff (PDF)

Down‐regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells

International journal of cancer, 2009-10, Vol.125 (7), p.1626-1639

2009

Volltextzugriff (PDF)

Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells

Journal of cell science, 2007-04, Vol.120 (8), p.1393-1404

2007

Volltextzugriff (PDF)

Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastrophe

Cell death & disease, 2020-07, Vol.11 (7), p.499-499, Article 499

2020

Volltextzugriff (PDF)

Discovery and Validation of Novel Biomarkers for Detection of Epithelial Ovarian Cancer

Cells (Basel, Switzerland), 2019-07, Vol.8 (7), p.713

2019

Volltextzugriff (PDF)

Caveolin-1 Is Down-Regulated in Human Ovarian Carcinoma and Acts as a Candidate Tumor Suppressor Gene

The American journal of pathology, 2001-11, Vol.159 (5), p.1635-1643

2001

Volltextzugriff (PDF)

1 – 25 von 281

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(202)
Mit Volltextzugriff
(241)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(211)
Deutsch
(69)
Russisch
(2)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Life Sciences & Biomedicine
(116)
Humans
(86)
Oncology
(52)
Animals
(51)
Biological And Medical Sciences
(43)
Biochemistry & Molecular Biology
(37)
Female
(36)
Tumors
(31)
Gene Expression
(30)
Cell Biology
(27)
Mice
(24)
Medical Sciences
(23)
Signal Transduction
(23)
Fundamental And Applied Biological Sciences. Psychology
(22)
Rats
(20)
Cell Line, Tumor
(19)
Gene Expression Regulation, Neoplastic
(19)
Mutation
(19)
Male
(17)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Silencing effects of mutant RAS signalling on transcriptomes

Guidelines for the selection of functional assays to evaluate the hallmarks of cancer

Ras-mediated deregulation of the circadian clock in cancer

Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors

Editorial: Hallmark of cancer: Evasion of growth suppressors

Non-Canonical Hedgehog Signaling Is a Positive Regulator of the WNT Pathway and Is Required for the Survival of Colon Cancer Stem Cells

Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D cultures

RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data

Evaluation of JQ1 Combined With Docetaxel for the Treatment of Prostate Cancer Cells in 2D- and 3D-Culture Systems

Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures

Network quantification of EGFR signaling unveils potential for targeted combination therapy

A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-NTRK1 gene fusion with durable clinical response to crizotinib: a case report

DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer

The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells

HMGA2 gene is a promising target for ovarian cancer silencing therapy

VIST - a Variant-Information Search Tool for precision oncology

A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer

IC50: an unsuitable measure for large-sized prostate cancer spheroids in drug sensitivity evaluation

Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells

Down‐regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells

Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells

Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastrophe

Discovery and Validation of Novel Biomarkers for Detection of Epithelial Ovarian Cancer

Caveolin-1 Is Down-Regulated in Human Ovarian Carcinoma and Acts as a Candidate Tumor Suppressor Gene

Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL

Suchergebnisse filtern